Search Results - Beth Muldrew
- Showing 1 - 2 results of 2
-
1
Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data by Nicholas Swart, Roberta Maroni, Beth Muldrew, Peter Sasieni, Rebecca C. Fitzgerald, Stephen Morris
Published in EClinicalMedicine (2021-07-01)Get full text
Article -
2
Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal... by Judith Offman, Beth Muldrew, Maria O’Donovan, Irene Debiram-Beecham, Francesca Pesola, Irene Kaimi, Samuel G. Smith, Ashley Wilson, Zohrah Khan, Pierre Lao-Sirieix, Benoit Aigret, Fiona M. Walter, Greg Rubin, Steve Morris, Christopher Jackson, Peter Sasieni, Rebecca C. Fitzgerald, on behalf of the BEST3 Trial team
Published in BMC Cancer (2018-08-01)Get full text
Article
